Skin

Peptides in
skincare

Peptides are common ingredients in creams and serums. The four types, what the human trials measured, and how the US, EU, UK and Australia regulate them.

Short answerCompound research · 7 min read · Updated 18 Nov 2026

Peptides in skincare are short chains of amino acids added to creams and serums. Reviews sort them into four types: signal, carrier, neurotransmitter-inhibitor and enzyme-inhibitor peptides. Many of their human trials are small and short and measure how skin looks, and a 2026 meta-analysis of 19 randomised trials found only two that applied peptides to the skin.

Key takeaways

  • Reviews group skincare peptides into four types: signal, carrier, neurotransmitter-inhibitor and enzyme-inhibitor peptides.
  • Well-known examples are palmitoyl pentapeptide-4 (pal-KTTKS), copper tripeptide-1 (GHK-Cu) and acetyl hexapeptide-8.
  • Many trials are small and short and measure appearance; a 2026 meta-analysis of 19 randomised trials included only two of peptides applied to the skin.
  • How far these peptides get into the skin is uncertain: a 2025 review says acetyl hexapeptide-8 faces limited permeability through the skin’s outer layer.
  • In the US, cosmetics need no FDA approval before sale, but a claim to affect the body’s structure or function makes a product a drug.

01The four types of skincare peptide

A 2009 review sorted the peptides used on ageing skin into four groups. Later reviews still use them. Each group is defined by what the peptide was designed to do, not by what trials showed.

TypeDesigned toExample (ingredient name)Human trials we cite
Signal peptidesAct as a signal to skin cells (fibroblasts) to make structural proteins such as collagenPalmitoyl pentapeptide-4 (pal-KTTKS)One randomised split-face trial, 93 women, 12 weeks (2005)
Carrier peptidesCarry substances skin cells use, such as copperCopper tripeptide-1 (GHK-Cu)Small studies, mostly conference reports; see topical GHK-Cu
Neurotransmitter-inhibitor peptidesMimic part of SNAP-25, a protein nerve endings use to release signals to muscleAcetyl hexapeptide-8One randomised placebo-controlled trial, 60 adults, 4 weeks (2013)
Enzyme-inhibitor peptidesSlow enzymes such as matrix metalloproteinases (MMPs), which break down skin’s structural proteinsDipeptide-2, tripeptide-2Not covered by the trials on this page

Names matter here. Pal-KTTKS is the palmitoyl form of the five-amino-acid peptide KTTKS, also called pentapeptide-4; the palmitoyl form is sold under the trade name Matrixyl. Acetyl hexapeptide-8 is sold as Argireline. A 2026 review warns that a defined peptide such as palmitoyl pentapeptide-4 “should not be equated with hydrolyzed collagen or a placenta-derived peptide mixture.” Collagen supplements are a separate topic: collagen peptides vs research peptides.

02What the human trials measured

Cosmetic trials measure how skin looks. Here are three, with their design and who ran them.

Palmitoyl pentapeptide-4, 2005. In a trial run at Procter & Gamble, 93 women aged 35 to 55 used a moisturiser with pal-KTTKS on one side of the face and the same moisturiser without it on the other, for 12 weeks. It was double-blind and randomised, and the outcome was wrinkles and fine lines measured in facial images. It is one industry-run trial.

Acetyl hexapeptide-8, 2013. Researchers at a hospital in Xi’an, China, randomised 60 adults, three to one, to acetyl hexapeptide-8 or placebo on the wrinkles around the eyes for 4 weeks. They graded the lines by eye and measured skin roughness from silicone casts of the skin.

Copper tripeptide-1 (GHK-Cu), 2006. After laser resurfacing around the mouth, patients were randomised to skin-care regimens with or without GHK-Cu; 13 completed. Computer analysis and blinded evaluators found no significant difference in redness, wrinkles or overall skin quality, though patients using GHK-Cu products rated their skin quality higher. The other GHK-Cu skin studies are mostly conference reports: topical GHK-Cu lists them.

03Do peptides in skincare work?

The best summary we found says the evidence for peptides applied to the skin is thin.

A 2026 systematic review and meta-analysis pooled 19 randomised trials with 1,341 participants. Seventeen tested peptides taken by mouth; only two tested peptides applied to the skin. The authors write that the wrinkle effect they found was “largely attributable to oral formulations, whereas topical formulations showed limited impact”, and that the imbalance between the two routes constrains definitive conclusions. Products taken by mouth are not skincare, so the pooled result says little about creams.

A 2026 narrative review of peptides in aesthetic dermatology, covering topical and oral products, weighed the controlled human studies and found that “many trials are limited by small samples, short follow-up, industry sponsorship, or multi-ingredient formulations”, and that the evidence supports “product-specific interpretation rather than interchangeability across peptide classes or administration routes.” In plain terms: a trial of one peptide in one cream tells you about that cream, not about peptides in general.

Getting into the skin is part of the problem. A 2025 review of acetyl hexapeptide-8 says that, because it is water-loving and relatively large, it “faces limited permeability through the lipophilic stratum corneum”, the skin’s outer layer, and that its ability to reach the junctions between nerves and muscles “remains uncertain”.

04How skincare peptides are regulated

Each market defines a cosmetic by what it is for. Here is what that means for a peptide cream.

MarketBefore saleWhere the line is
United States (FDA)No approval: “cosmetic products and ingredients, with the exception of color additives, do not require FDA approval before they go on the market.” Since the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), facilities register, products are listed with their ingredients, and serious adverse events must be reported within 15 business days, with exemptions for some small businesses.Intended use decides. A product “intended to affect the structure or any function of the body” is a drug; FDA’s examples of drug claims include promises to “regenerate cells”.
European Union (Regulation 1223/2009)A named “responsible person” must have the product safety-assessed and notify it to the European Commission before it goes on the market, and keep a product information file with “proof of the effect claimed” where justified.A cosmetic is placed on external parts of the body, the teeth or the lining of the mouth “with a view exclusively or mainly” to cleaning, perfuming, changing appearance, protecting, keeping in good condition or correcting body odours. Claims “shall not be used to imply that these products have characteristics or functions which they do not have.”
Great Britain (OPSS)The same regulation as amended after Brexit: a responsible person with a UK address, a safety assessment by a qualified assessor, and notification to the Office for Product Safety and Standards before sale.The responsible person must “be able to prove that any claims made when marketing the product are correct.”
AustraliaCosmetic ingredients can be industrial chemicals, regulated by the Australian Industrial Chemicals Introduction Scheme.The Industrial Chemicals Act 2019 defines a cosmetic by appearance-type purposes and excludes “a therapeutic good within the meaning of the Therapeutic Goods Act 1989”.

None of the rules we read requires a regulator to check, before sale, that a cream works. The EU and GB require evidence for a product’s claimed effects to be kept on file (in the EU, where the effect justifies it); the US relies on intended use and enforcement. How cosmetic peptides differ from medicines and research compounds: types of peptides.

05What we don’t know

  • How much of a peptide in a cream reaches living skin cells in people. The reviews we cite call skin penetration a central limit.
  • Whether results for one product apply to another with the same peptide. Formulations, strengths and the other ingredients differ.
  • What topical peptides do over years. The trials we cite lasted 4 to 12 weeks.
  • How much of the evidence would survive independent replication. Many trials are small and industry-sponsored.

For the copper peptide in detail, see the GHK-Cu research guide and skin research.

This is a plain-English summary of public documents and studies, checked on 18 Nov 2026. It is not legal or medical advice.

RefSources

  1. Gorouhi F, Maibach HI. Role of topical peptides in preventing or treating aged skin. Int J Cosmet Sci, 2009;31(5):327–345. PMID 19570099. pubmed.ncbi.nlm.nih.gov/19570099/
  2. Zdrada-Nowak J, Surgiel-Gemza A, Szatkowska M. Acetyl hexapeptide-8 in cosmeceuticals: a review of skin permeability and efficacy. Int J Mol Sci, 2025;26(12):5722. PMID 40565185 (abstract and Table 1 read in PMC). pmc.ncbi.nlm.nih.gov/articles/PMC12193160/
  3. Yi KH, Kim HS, Lee HE, et al. Peptides in aesthetic dermatology: classification, fibroblast-centered mechanisms, delivery technologies, and clinical evidence. Life (Basel), 2026;16(10):1660. PMID 42942246. pmc.ncbi.nlm.nih.gov/articles/PMC13705772/
  4. Nukaly HY, Halawani IR, Irtaza HM, et al. Oral and topical peptides for skin aging: systematic review and meta-analysis of randomized controlled trials. Front Med (Lausanne), 2026;13:1618306. PMID 41924746 (full text read in PMC). pmc.ncbi.nlm.nih.gov/articles/PMC13037056/
  5. Robinson LR, Fitzgerald NC, Doughty DG, et al. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci, 2005;27(3):155–160. PMID 18492182. pubmed.ncbi.nlm.nih.gov/18492182/
  6. Wang Y, Wang M, Xiao S, et al. The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study. Am J Clin Dermatol, 2013;14(2):147–153. PMID 23417317. pubmed.ncbi.nlm.nih.gov/23417317/
  7. Miller TR, Wagner JD, Baack BR, Eisbach KJ. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Arch Facial Plast Surg, 2006;8(4):252–259. PMID 16847171. pubmed.ncbi.nlm.nih.gov/16847171/
  8. Gomes A, Bessa LJ, Fernandes I, et al. Boosting cosmeceutical peptides: coupling imidazolium-based ionic liquids to pentapeptide-4 originates new leads with antimicrobial and collagenesis-inducing activities. Microbiol Spectr, 2022;10(4):e0229121. PMID 35950860 (cited for identity only: pentapeptide-4 is KTTKS, and its N-palmitoyl derivative is Matrixyl). pubmed.ncbi.nlm.nih.gov/35950860/
  9. U.S. Food and Drug Administration. Is it a cosmetic, a drug, or both? (Or is it soap?) and Modernization of Cosmetics Regulation Act of 2022 (MoCRA). Web pages, content current as of 11 Sep 2024 and 29 Oct 2026; read 18 Nov 2026. www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic…
  10. Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products, Articles 2, 3, 4, 10, 11, 13 and 20. EUR-Lex, read 18 Nov 2026. eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32009R1223
  11. Office for Product Safety and Standards. Making cosmetic products available to consumers in Great Britain. Guidance, published 4 Oct 2021; read 18 Nov 2026. www.gov.uk/guidance/making-cosmetic-products-available-to-co…
  12. Industrial Chemicals Act 2019 (Cth), sections 3 and 9 (“cosmetic”). Federal Register of Legislation, compilation C2024C00495 in force from 14 Oct 2024; text read via the Register’s API 18 Nov 2026. www.legislation.gov.au/C2019A00012/latest/text

Plain-English summary of public sources, not legal or medical advice. Last checked 18 Nov 2026.

Questions

What are skincare peptides designed to do?

Each type is designed for a different job: signal peptides to prompt skin cells to make structural proteins, carrier peptides to deliver copper, neurotransmitter-inhibitor peptides to mimic part of a nerve protein, and enzyme-inhibitor peptides to slow enzymes that break down collagen. Those are design aims; the human trials are small and measure appearance.

Do peptides get through the skin?

Often not well, according to the reviews we cite. A 2025 review says acetyl hexapeptide-8 faces limited permeability through the skin’s outer layer, and the authors of a 2026 meta-analysis note that topical peptides are limited by penetration of that layer unless advanced delivery systems are used.

Is acetyl hexapeptide-8 like Botox?

It was designed as a topical alternative to botulinum toxin, modelled on part of the nerve protein SNAP-25. A 2025 review says its ability to reach the junctions between nerves and muscles through the skin remains uncertain.

Do skincare peptides need FDA approval?

Not as cosmetics. FDA says cosmetic products and ingredients, apart from colour additives, need no approval before sale. Intended use decides: a product intended to affect the structure or any function of the body is a drug.

Are skincare peptides tested before they are sold?

For safety, in part: the EU and Great Britain require a safety assessment before sale, and in the US the responsible person must keep records supporting the product’s safety. For effect, none of the rules we read requires a regulator to check, before sale, that a cream works.

Evidence before hype.

One email a week: new research explained and regulatory changes. No prices, no hype.

Get the 6:00 brief

Free. Unsubscribe any time.

Written by 6AM Research. Drafted from primary sources; every claim links to its source, and the page is dated. Editorial policy · How we check every page